Skip to main content
Cancer Explained
Donate

NewsPublic figure

Anastacia, Breast Cancer, and the Power of Awareness

Singer Anastacia has spoken publicly about being diagnosed with breast cancer and about raising awareness. Here's what breast cancer really is, according to the National Cancer Institute.

By Cancer Explained Editorial TeamPublished Updated

A plain-language summary based on public reporting and trusted sources, linked below.

A female doctor and male doctor review scans together on monitors
A female doctor and male doctor review scans together on monitors — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

Twice, ten years apart

Anastacia is an American singer known for "I'm Outta Love" and "Left Outside Alone." BBC News reports that she was treated for breast cancer in 2003, and that in February 2013 she cancelled a European tour after being diagnosed a second time.

The BBC noted what she had said after the first diagnosis. Her experience had taught her the importance of early detection, and she urged other women to have mammograms.

In October 2013 she described the outcome in her own words. "l was diagnosed with breast cancer for the second time earlier this year and am currently in the final stages of recovery after undergoing a double mastectomy," she said, timing the statement to Breast Cancer Awareness Month.

That is the public account, and her treatment decisions were hers to make. What follows is the medicine behind the choices anyone in that position faces.

First things first: what is being diagnosed

Breast cancer starts when cells in the breast grow out of control. Most begin in the ducts, the thin tubes carrying milk toward the nipple, and some begin in the lobules, the glands that produce milk.

The National Cancer Institute's clinician guidance sets out the diagnostic path: "mammography, ultrasonography, breast magnetic resonance imaging (MRI), if clinically indicated," and then biopsy. Imaging raises a question, and only tissue answers it.

Three results on the pathology report then steer treatment. NCI lists estrogen receptor status, progesterone receptor status, and HER2 status alongside stage, grade, and menopausal status. Receptors are docking sites on the cancer cell, and NCI states that estrogen receptor status is measured mainly by immunohistochemistry, a stain applied to the tissue, where "any staining of 1% of cells or more is considered positive for ER."

Lumpectomy or mastectomy, and what the evidence says

This is the decision Anastacia's story raises, and the data on it is unusually clear.

NCI lists the surgical options for early breast cancer as breast-conserving surgery plus radiation therapy, or mastectomy with or without breast reconstruction. A modified radical mastectomy removes the entire breast along with lymph nodes from the armpit.

On survival, NCI states that outcomes are "equivalent with any of these options," citing the EORTC-10801 trial and other prospective randomized trials. Removing more breast tissue does not, by itself, mean living longer.

That does not make the choice trivial. Breast-conserving surgery normally requires weeks of radiation afterward. Mastectomy avoids that in many cases, may lower the chance of the cancer returning in that breast, and involves a bigger operation and decisions about reconstruction. NCI also notes that inflammatory breast cancer rules out breast-conserving therapy entirely.

Anyone weighing this should be told plainly that survival is not the variable being traded. Recurrence risk in the breast, radiation, reconstruction, symmetry, and how each option feels to live with are the variables.

Being diagnosed before screening age

Anastacia was in her thirties at her first diagnosis. That is below the age at which routine screening begins.

CDC states the U.S. Preventive Services Task Force recommendation: women aged 40 to 74 at average risk should have a mammogram every two years. CDC adds that different schedules may apply to women at higher than average risk.

That leaves a gap. For women under 40, breast cancer is usually found because someone noticed a change, not because a scan was scheduled. Her advice about early detection was really advice about paying attention.

Higher-than-average risk changes the arithmetic. A strong family history, or a known inherited gene change such as BRCA1 or BRCA2, is a reason to ask about genetic counseling and earlier or additional imaging, well before 40.

When to get checked

CDC names these warning signs. Any of them earns an appointment now.

  • A new lump in the breast or armpit
  • Thickening or swelling of part of the breast
  • Dimpled, irritated, red, or flaky breast or nipple skin
  • A nipple turning inward, or nipple pain
  • Discharge other than breast milk, including blood
  • A change in one breast's size or shape
  • Breast pain unrelated to your cycle

CDC adds that non-cancerous conditions cause these too. That is an argument for being checked, not for waiting to see.

A second diagnosis is not automatically a return

When cancer appears again, two different things may be happening. A recurrence is the original cancer coming back. A second primary is a brand new cancer, staged and treated on its own terms.

NCI's guidance distinguishes a recurrence after breast-conserving surgery from "a second primary cancer in the contralateral" breast, meaning the other side. The distinction changes staging and treatment, and it is a fair thing to ask a team to state explicitly.

What the numbers describe

The American Cancer Society put 2026 at 321,910 new cases of female breast cancer and 42,140 deaths in the United States. The rate of new cases is 132.5 per 100,000 women per year, and the median age at diagnosis is 64.

Five-year relative survival across all stages is 91.9 percent, using cases from 2016 through 2022. Relative survival compares people with the diagnosis to people of the same age without it. By stage, SEER lists 100.0 percent for localized disease, 87.5 percent when nearby nodes are involved, and 33.8 percent once the cancer has reached distant organs.

In that same 2016 to 2022 cohort, SEER records 64 percent of cases as localized when found and 6 percent as distant. That distribution is why noticing a change early carries so much weight, especially for women too young for routine screening.

These are group averages from hundreds of thousands of records. They describe populations, not people.

Sources

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Breast cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI